Rapidly and efficiently load dendritic cells with proteins or cell lysates using a cGMP-compliant, commercially validated delivery platform that scales from bench to bedside. MaxCyte’s electroporation-based platform efficiently delivers proteins with minimal cell disturbance, high levels of cell viability and no appreciable change in dendritic cell phenotype or T cell activation functions. Easily control the degree of antigen loading for optimum presentation of processed antigen in functionally mature DC, resulting in enhanced T cell activation and anti-tumor efficacy.
Learn about cutting-edge applications, new resources, and upcoming events.
Subscribe to our e-Newsletter